Keep out of the reach and sight of children.
Do not use [Invented name] after the expiry date, which is stated on the carton and bottle. The expiry date refers to the last day of that month.
Store the unopened bottle in a refrigerator (between 2°C and 8°C), protected from light.
After opening the bottle it is not necessary to store the bottle in a refrigerator but do not store it above 25°C. Use within 4 weeks of opening. When you are not using [Invented name], keep the bottle in the outer carton, in order to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6 FURTHER INFORMATION
What [Invented name] contains
The active substance is latanoprost.
1 ml of eye drops contains 50 micrograms latanoprost.
The other ingredients are: benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate (E339a) and anhydrous disodium hydrogen phosphate (E339b) dissolved in water for injections.
page 4 of 5
What [Invented name] looks like and contents of the pack
[Invented name] Eye Drops, Solution is a clear, colourless liquid.
[Invented name] is available in a pack size of 1 carton.
Each carton contains one bottle of [Invented name]. Each bottle contains 2.5ml of [Invented name] Eye Drops, Solution.
Marketing Authorisation Holder and Manufacturer
Dr Reddy’s Laboratories (UK) Ltd
6, Riverview Road, Beverley,
East Yorkshire, HU17 0LD
Engeland
Nummer van de vergunning voor het in de handel brengen
RVG 109337
This medicinal product is authorised in the Member States of the EEA under the following names
To be completed nationally
This leaflet was last approved in {MM/YYYY }.
page 5 of 5